Miguel Forte, MD, PhD ISCT President MC4TX Belgium As a well-established tradition, ISCT will hold its annual meeting at the beginning of May. This year we will gather in Dublin from the 6th to the 10th of May. It is an unmissable event as the largest global cell and gene therapy...
Jessica Sue, BSc, MHSM ISCT ANZ LRA Committee Member Quality Manager Sydney Cord Blood Bank Sydney Children’s Hospitals Network The ISCT Australia New Zealand (ANZ) Legal & Regulatory Affairs Committee (LRA), in collaboration with the Global Regulatory Task Force, is proud to present...
Jessica Sue Junior Associate Editor Telegraft/ISCT ESP Leadership Development Program Quality Manager, Sydney Cord Blood Bank, Sydney Children’s Hospitals Network Junior Associate Editor ISCT ESP Leadership Development Program Having worked in cord blood (CB) banking for much of my...
Joaquim Vives, PhD Contributing Editor, Telegraft Banc de Sang i Teixits Barcelona, Spain I earned my doctorate in 2002… that’s over 20 years ago, now (!) Throughout this time in research, I had the privilege of mentoring a diverse array of pre-doctoral...
Conrad Russell Y. Cruz MD PhD Senior Editor, Telegraft Children’s National Hospital, Washington DC The organizational psychologist Adam Grant writes that critical thinking requires us to: “(1) Be 10% more skeptical of people you agree with—and 10% more charitable to...
Janet Macpherson, Ph.D. Director SpanCyte Pty Ltd Sydney, NSW, Australia As we start 2025, many of our cell and gene therapy colleagues are heading to the first big events of the year. JPM Healthcare in San Francisco (13-16 Jan 2025) followed by Advanced Therapies...
Ashley Krull, Ph.D. Associate Director, Cell Therapy Manufacturing and Engineering James Cancer Hospital Cellular Therapy Laboratory Assistant Professor, Hematology The Ohio State University Columbus, Ohio, United States As 2024 draws to a close, the Editorial Board of the Telegraft is...
Adaeze Ekwe, PhD Junior Associate Editor ISCT ESP Leadership Development Program Cellular therapies have significantly evolved since inception as one of the most innovative and transformative approaches to treat diseases, offering new hope for patients with conditions previously deemed...
Janet Macpherson, PhD Senior Editor Cytiva Australia As the editorial team discussed the September issue of Telegraft, I proposed CAR T-cells for autoimmune disease as the topic of my editorial. Imagine my surprise, when reviewing the submitted content just days before publication,...
Shyam Bhakta, MD, MBA National Center for Regenerative Medicine Case Western Reserve University Cleveland, Ohio, USA Human immunodeficiency virus (HIV) remains a significant global challenge and demands continuous progress in therapeutic approaches (1). Since the start of the epidemic, 85...